Sevoflurane-Remifentanil Interaction: Multiple Response Surfaces, Validation of Calibration Stimuli, Validation of the Intraoperative Isobole Concept and Investigating Remifentanil Induced Opioid Tolerance

NCT00522587 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-01-30

No results posted yet for this study

Summary

During this study, the pharmacodynamic interactions between sevoflurane and remifentanil will be studied.

Conditions

  • Anesthesia

Interventions

DRUG

Fixed sevoflurane dose 1

Dose 1 of sevoflurane

DRUG

Fixed sevoflurane dose 2

Dose 2 of sevoflurane

DRUG

Fixed sevoflurane dose 3

Dose 3 of sevoflurane

DRUG

Fixed sevoflurane dose 4

Dose 4 of sevoflurane

DRUG

Fixed sevoflurane dose 5

Dose 5 of sevoflurane

DRUG

Fixed sevoflurane dose 6

Dose 6 of sevoflurane

DRUG

Fixed remifentanil dose 1

Dose 1 of remifentanil

DRUG

Fixed remifentanil dose 2

Dose 2 of remifentanil

DRUG

Fixed remifentanil dose 3

Dose 3 of remifentanil

DRUG

Fixed remifentanil dose 4

Dose 4 of remifentanil

DRUG

Fixed remifentanil dose 5

Dose 5 of remifentanil

DRUG

Fixed remifentanil dose 6

Dose 6 of remifentanil

Sponsors & Collaborators

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Michel Struys, MD, PhD · University Hospital, Ghent

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-07-31
Completion
2011-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00522587 on ClinicalTrials.gov